FertilityBlend study
This article was originally published in The Tan Sheet
Executive Summary
Multi-center trial on Daily Wellness Company's FertilityBlend supplements for women, men will follow 200 couples who have tried for over six months to become pregnant. Three-month trial builds on pilot study of 29 women that resulted in pregnancies for four of 14 women in treatment group, compared with no pregnancies in placebo arm. FertilityBlend for women contains chasteberry, l-arginine; men's product has l-carnitine, ferulic acid to "improve the health of sperm," firm says. Supplement is available nationwide at food, drug outlets, health food stores such as GNC...
You may also be interested in...
FertilityBlend
"Nutritional supplementation may provide an attractive alternative or complement to conventional fertility therapy," according to a study published in the April Journal of Reproductive Medicine. The double-blind placebo-controlled study followed thirty women aged 24-46 who had tried unsucessfully to conceive for 6 to 36 months. Women received three capsules of either FertilityBlend or placebo per day for three menstrual cycles. After five months, five of the 15 women in the supplement group were pregnant compared to no pregnancies in the placebo group, Lynn Westphal, MD, Department of Obstetrics & Gynecology, Stanford University, et al. find. Daily Wellness Company's FertilityBlend contains chasteberry, l-arganine. An earlier study evaluating the supplement was announced in 2002 (1"The Tan Sheet" May 20, 2002, In Brief)...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.